SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
This report provides an overview of actinide intakes, case studies and associated psychological challenges and concerns. It also details ways to mitigate harm before and following an intake.
Objectives: 1) List the revised initial response and supplemental actions while responding to a major injury inside of a radiological area; 2) List the initial response and supplemental actions while responding to a minor injury inside of a radiological area; 3) List the initial response and supplemental actions for responding to a Continuous Air Monitoring (CAM) alarm; 4) List the initial response and supplemental actions for responding to a radioactive spill; 5) List the initial response and supplemental actions of responding to an Area Radiation Monitor (ARM) alarm; 6) List the initial response and supplemental actions of an Electronic Personal Dosimeter (EPD) dose and dose rate alarm; 7) List the initial response and supplemental actions of responding to a Stationary Contamination Monitor (SCM) alarm; 8) Identify the methods to perform personnel decontamination.
Standard first aid is applied before contamination control whenever it is considered to have life-saving value or is important to the patient for the relief of pain or prevention of disability. It is the obligation of all who assist a patient to render such aid within the limits of their training and qualifications.
In our work environment, one of the major concerns of radiological control is the prevention of personnel contamination. When personnel contamination has been identified, it is the responsibility of the RCTs to perform or oversee the decontamination of the individual using the best methods available. n this course we will address the methods used to detect personnel contamination, the factors that determine decontamination actions, the responsibilities of the RCTs, and the approved methods for decontamination of personnel. This course will prepare the student with the skills necessary for RCT qualification.
Course Overview: Tritium is a radioactive isotope of hydrogen which has characteristics that require workers understand what should be done to work safely and responsibly around it. Tritium is used for defense applications, experimental purposes for general research, and is a byproduct of some of the work that is done at LANL. Practical guidance offered in this training will inform safe handling to minimize negative impacts on personnel, the workspace, and the surrounding environment. This course, Tritium Safety Self-Study (Course 11952), provides information on the physical, chemical, and radioactive properties of tritium; sources of tritium; uses of tritium; biological effects of tritium; radiological control methods for tritium; monitoring methods of tritium; tritium waste minimization and handling; and alarms and proper response to abnormal conditions in a tritium facility. Course Objectives: When you have completed this course, you will be able to: Identify the physical, chemical, and radioactive properties of tritium; Identify the sources of tritium; Identify the uses of tritium; Identify the modes of tritium exposure; Identify the biological effects of tritium; Identify the radiological control methods of tritium; Identify methods used to monitor for tritium; Identify tritium waste minimization and handling techniques; Identify proper response to abnormal conditions in tritium facilities.
This module, RCT Module 2.08 Radiological Source Control Course 8774, is intended for training incoming Radiological Control Technicians (RCTs) for Los Alamos National Laboratory.
Slides and notes on Radiation and Contamination Surveys.
Abstract not provided.
The purpose of this exercise is to test participants’ nuclear accident dosimeters (NADs) and personnel to the requirements established by American National Standards Institute (ANSI), Health Physics Society (HPS) standard ANSI/HPS-N13.3-2013 (R2025) Dosimetry for Criticality Accidents. IER-634 is the second nuclear accident dosimetry exercise taking place at the Armed Forces Radiobiology Research Institute (AFRRI) in Bethesda, MD, a Department of Defense (DOD) facility. This effort continues use of the high-dose neutron exposure test bed maintained by the DOD and represents the continued collaboration between the DOD and Department of Energy (DOE). Previous work at AFRRI included a reactor characterization (IER 484) in 2023 and a nuclear accident intercomparison exercise (IER-602) in 2024.
The isotopic ratios of fission gas would provide important source information of a nuclear fuel sample found in the environment. However, it is believed that during a reactor accident like Chornobyl all fission gas is lost and that the radioactive particles found in the Chornobyl Exclusion Zone today are depleted in gases by the initial explosion and subsequent fire. We disprove this hypothesis by detection and analysis of trapped krypton and xenon in these particles. Our analysis of krypton and xenon isotopes by noble gas mass spectroscopy in combination with resonance ionization mass spectrometry establishes that important information about reactor operations like age, neutron flux and plutonium fission fraction can still be reconstructed from individual micrometer-sized particles even after decades of weathering in the environment.
The Los Alamos National Laboratory has required usage of facemasks “whenever interacting with or near others." The present document estimates the respiratory protection factor of homemade facemasks to be 1.4 and 1.2 for aerosol particles, below and above 0.3 μm diameter, respectively. This includes an estimated leakage of 70% and 52% for aerosol particles below and above 0.3 μm diameter, respectively.
This presentation was prepared for the request from Northern New Mexico College. "For your talk I’m thinking a bit more detail about the specific sampler you’re bringing, and the types in use at LANL, then setup and ops check, loading and removing a filter, cutting out the right size circle, reading the sample (we have a couple Eberline SAC-4s and Ludlum 2929s here), and radon/daughters corrections."
Our team calculated ‘clinical decision levels’ at which treatment may be warranted (i.e., bioassay and wound measurements which correspond to specific dose thresholds). The actual risk to the patient corresponding to this dose threshold is uncertain – the CED may not tell the whole story. We recently reviewed LANL medical records to characterize adverse events associated with treatment. Future work should include medical records from other institutions and a review and analysis of data to quantify benefit of treatment with a focus on the question, "What factors predict whether treatment will be beneficial?"
Iodine is a chemical element with atomic number 53. Iodine-127 is stable (non-radioactive) and commonly found in nature. Elemental iodine is a purple-colored solid at room temperature and pressure, but spontaneously sublimates (turns into vapor). Iodine is an essential element for life, and is required for proper functioning of the thyroid. Iodine is present in many foods, and is readily absorbed by the body and concentrated in the thyroid gland. A fraction of iodine ingested or inhaled is rapidly removed by the kidneys. The rest of the inhaled or ingested iodine is absorbed the by thyroid and retained for many months. Iodine has a biological half-life of approximately 120 days in health individuals. The biological half-life can be shorter in individuals with hyperthyroidism, and longer in individuals with hypothyroidism. Iodine has a number of radioactive isotopes, most of which have relatively short half-lives (days or weeks). Short half-life iodine isotopes are useful for a variety of medical applications, including imaging and cancer therapy. For example, Iodine-123 (half-life 13 hours) is commonly used for medical imaging of the thyroid, while iodine-131 (half-life 8 days) is used for suppressing thyroid function in individuals with hyperthyroidism or ablating (killing) thyroid cells to treat thyroid cancer. Iodine-125 (half-life 59 days) is produced in nuclear reactors, and has medical uses. Although iodine-125 can be used for thyroid imaging, Iodine-123 is more commonly used for that purpose because of its shorter half-life and higher-energy emissions. Iodine-125 is more commonly used for cancer treatment, and can be processed into small metal pellets (seeds) inserted directly into a tumor. Iodine-125 emits low-energy x-rays which can kill tumor cells and generally cannot escape the tumor, sparing other tissues. Medical iodine for imaging or treatment is typically administered orally in the form a pill or liquid solution. A typical adult thyroid scan using iodine-123 involves having the patient swallow between one and four 0.1 millicuries pills, with the exact dose dependent on the patient’s weight. This results in a whole-body committed effective dose of 80 – 320 mrem, and a thyroid equivalent dose of 1443 – 5772 mrem. Note that the whole-body effective dose relates to the overall cancer risk, while the larger equivalent dose to the thyroid only indicates that most of this risk is the result of exposure to the thyroid. These doses are considered safe, although the procedure is not recommended for pregnant or breastfeeding women. In contrast, the quantities of iodine-131 used for treatment of hyperthyroidism and thyroid cancers are much higher. For treatment of hyperthyroidism, 4 – 10 millicuries are administered, while for thyroid cancer the administration can range from 50 – 150 millicuries of I-131. In addition to medical exposures, large populations were exposed to radioiodine as result of the atomic bombings of Hiroshima and Nagasaki in Japan, and the Chernobyl nuclear accident. These populations have been carefully followed for many years to assess the effect of their radiation exposures on cancer risk. As a result, a great deal is known about the cancer risks associated with radioiodine exposure. Because iodine is concentrated in the thyroid, the principal risk of exposure to radioiodine is thyroid cancer. Children have the highest risk of thyroid cancer after exposure to radioactive iodine. According to a large study of Japanese atomic bomb survivors, an effective dose of one Sievert (100,000 mrem) has been observed to increase the risk of thyroid cancer by a factor of 9.5 in children aged zero to nine years old, by a factor of 3 in children aged 10 to 19 years old, and by barely detectable amounts in adults. Another way of quantifying the risk from radioiodine exposure is from risk coefficients, which provide the risk per unit intake of radionuclides in terms of both morbidity (any cancer) and mortality (death). Both morbidity (risk of cancer) and mortality (death) risks are shown in the table below. Note that because thyroid cancer is almost never fatal, the morbidity coefficients are much larger than the mortality coefficients.
With the approval of President Franklin D. Roosevelt to begin the research on a nuclear bomb in 1941 to the last test conducted by the U.S. in 1992, the fifty-year history of the nuclear weapons testing program has been an expansive topic of research. The program's growth is credited to the race to build the first atomic weapon for war. The termination of the Soviet Union and many other factors, including concerns about the adverse health effects of radioactive fallout, influenced the decline of the need for the program. The discovery of the negative health effects caused by low-level radiation and the subsequent studies influenced sitting U.S. presidents in passing policies that significantly impacted the nuclear weapons testing program.
This report presents the work that was performed to determine the neutron energy spectrum (spectrum) of the Multi-Mission Radioisotope Thermoelectric Generator (MMRTG) with a neutron Multi-Sphere Spectrometer (MSS). The spectrometer measurements were performed when the generator is in an INL Materials and Fuels Complex (MFC) laboratory. The measurements were used in a spectrum unfolding software to calculate the neutron spectrum. Based on initial testing of the MSS spectrometer and experience with the unfolding software, an MMRTG spectrum is reported and a justification for the spectrum is provided.
The autonomous systems within the Mobile Hot Cell provide advanced capabilities over traditional hot cells, pushing the boundaries of these systems in harsh environments. The degraded state of some radiological devices and the variety of designs present a series of challenges that require innovative tooling and procedural solutions. By leveraging technical knowledge and experience from disposition experts at SwRi and other institutions, initial design concepts were produced using rapid prototyping techniques. These concepts were then validated and optimized in a non-hazardous test bed, resulting in iterative improvements at minimal cost.
Total effective radiation dose from airborne releases was calculated using air dispersion modeling performed by the National Oceanic and Atmospheric Administration (NOAA) Idaho Falls Office using their HYSPLIT computer model (Stein et al. 2015; Draxler et al. 2013), and the Dose Multi-Media (DOSEMM) dose assessment model (Rood 2019) . The objective of these calculations was to provide a grid of total effective dose across a model domain that encompasses a 50-mile (80-km) radius from any Idaho National Laboratory (INL) Site source. In addition to INL Site sources, releases from the Radiological and Environmental Sciences Laboratory (RESL) (IF-683) and IF-603 located at the INL Research Center (IRC) within the Idaho Falls city limits were also included. Due to tracking limitations, radionuclides released from IF-611 and IF-603 are modeled as released from IF-603. The dose results will be combined with GIS software to compute a total population dose for the calendar year (CY) 2024 and will be reported in the INL Annual Site Environmental Report (ASER). This report does not cover the population dose calculation and only documents generation of the gridded dose file.